PRP decreases IL-1β, IL-6, IL-8, and TNFα inflammatory genes expression while also reduces IL-1β and TNFα inflammatory cytokines production. PRP has also been showed to contain interleukin 1 receptor antagonist (IL-1RA), an anti-inflammatory cytokines that suppress IL-6 secretion.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
severe covid-19 patient in ICU
You may not be if
CKD on hemodialysis, HIV positive, hepatitis, pregnant, destroyed lung, cancer
Clareo Health | Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy